Endpoints News 生物医药· Kyle LaHucik·· 2026-10-15AI 评分31
OMass Therapeutics 融资 3.1 亿美元
OMass Therapeutics collects $310M to chase Neurocrine, Vertex in genetic adrenal disorder
AI 导读
英国牛津生物制药公司 OMass Therapeutics 已完成 3.1 亿美元私募融资。该公司旨在开发针对遗传性肾上腺疾病的治疗方案,正寻求追随 Neurocrine 和 Vertex 在该治疗领域的路径。这笔融资被视为近年来英国生物技术领域最大规模的私募融资之一。
正文
An Oxford-based drug developer has raised one of the largest private financings for a UK biotech in recent years as it seeks to follow in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news